Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority.
Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. · 2019
Read Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. by Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6788022.txt.
Introduction
Niedzwiedz and co-authors argue that depression and anxiety in people with cancer deserve far more clinical and research priority. A cancer diagnosis can shake mental health deeply. Poor mental health can in turn hinder treatment, recovery, quality of life, and survival. The authors synthesized systematic reviews published between 2012 and 2019 to make their case.
Many personal, social, and treatment-related factors feed distress in cancer patients. Measured prevalence varies wildly, from about 4 to 49% for depression across studies. Diagnostic interviews put the mean near 13%. Rates swing with cancer type: 3% in lung cancer, 31% in digestive tract cancer in one review. Better prevention and treatment research is the authors' central plea.
Catalog record
| CREATOR | Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority By Claire L Niedzwiedz, Lee Knifton, Kathryn A Robb, Srinivasa Vittal Katikireddi, Daniel J Smith Published in: BMC Cancer DOI: 10.1186/s12885-019-6181-4 ABSTRACT Abstract Background A cancer diagnosis can have a substantial impact on mental health and wellbeing. Depression and anxiety may hinder cancer treatment and recovery, as well as quality of life and survival. We argue that more research is needed to prevent and treat co-morbid depression and anxiety among people with cancer and that it requires greater clinical priority. For background and to support our argument, we synthesise existing systematic reviews relating to cancer and common mental disorders, focusing on depression and anxiety. We searched several electronic databases for relevant reviews on cancer, depression and anxiety from 2012 to 2019. Several areas are covered: factors that may contribute to the development of common mental disorders among people with cancer; the prevalence of depression and anxiety; and potential care and treatment options. We also make several recommendations for future research. Numerous individual, psychological, social and contextual factors potentially contribute to the development of depression and anxiety among people with cancer, as well as characteristics related to the cancer and treatment received. Compared to the general population, the prevalence of depression and anxiety is often found to be higher among people with cancer, but estimates vary due to several factors, such as the treatment setting, type of cancer and time since diagnosis. Overall, there are a lack of high-quality studies into the mental health of people with cancer following treatment and among long-term survivors, particularly for the less prevalent cancer types and younger people. Studies that focus on prevention are minimal and research covering low- and middle-income populations is limited. Conclusion Research is urgently needed into the possible impacts of long-term and late effects of cancer treatment on mental health and how these may be prevented, as increasing numbers of people live with and beyond cancer. Keywords: Mental health, Psychiatry, Cancer, Multimorbidity, Depression, Anxiety, Oncology, Survivorship BACKGROUND A cancer diagnosis can have a wide-ranging impact on mental health and the prevalence of depression and anxiety among people with cancer is high [1, 2]. Among those with no previous psychiatric history, a diagnosis of cancer is associated with heightened risk of common mental disorders, which may adversely affect cancer treatment and recovery, as well as quality of life and survival [3]. People who have previously used psychiatric services may be particularly vulnerable and at greater risk of mortality following a cancer diagnosis [4]. However, the mental health needs of people with cancer, with or without a prior psychiatric history, are often given little attention during and after cancer treatment, which is primarily focused on monitoring physical health symptoms and side effects. Advances in the earlier detection of cancer and improved cancer treatments means that people are now living longer with cancer, presenting a significant global challenge. The total number of people who are alive within 5 years of a cancer diagnosis was estimated to be 43.8 million in 2018 for 36 cancers across 185 countries [5], and in the United States alone, the number of cancer survivors is projected to rise exponentially from 15.5 million in 2016 to 26.1 million in 2040 [6]. The main objective of this article is to argue that more research is needed into the prevention, care and treatment of co-morbid depression and anxiety among people with cancer and highlight it as a growing clinical and policy priority. For background and to support our argument, we provide a current evidence review of systematic reviews relating to common mental disorders amongst people living with and beyond cancer. We cover the factors that may increase the risk of experiencing co-morbid depression and anxiety, epidemiology, and potential care and treatment options. We searched three key electronic databases: Medline, PsycINFO and CINAHL (Cumulative Index to Nursing and Allied Health Literature) for relevant reviews (favouring those using systematic methods) using the following search terms: (neoplasm OR carcinoma OR tumo*r OR cancer) AND (depression OR anxiety) AND review. Only English language articles were considered and searches were limited to the years 2012 to 2017 and updated during February 2019. These years were considered adequate to capture the main themes relating to cancer and common mental disorders in the current literature. The references of highly relevant articles were scrutinised for additional papers and a Google search for important grey literature was also conducted. A minority of significant research articles known to the authors were also consulted. MAIN TEXT Factors influencing the development of depression and anxiety among people with cancer A variety of factors are likely to interact to influence the development of depression and anxiety among people with cancer (summarised in Fig. 1), but these are not well understood [1], and require further research. Individual risk factors that may increase the risk of depression, similar to the general population, include demographic factors, such as age and gender, and social and economic factors such as unemployment, fewer educational qualifications and a lack of social support [7]. The development of depression and anxiety among people with cancer is also likely to depend on factors at the structural level, including healthcare costs and access, as well as access to welfare support, such as disability benefits, as cancer can have a significant financial impact [8, 9]. Several psychological factors are also important. A key factor is the presence of pre-existing mental health problems and their severity. Research has demonstrated that individuals who have previously accessed mental health services before a cancer diagnosis experience excess mortality due to certain cancers, which may reflect late diagnosis, inadequate treatment and a higher rate of adverse health behaviours [4, 10]. Personality factors, such as neuroticism, and existing coping skills may also contribute [11]. The risk of suicide among people with cancer is higher than the general population for certain diagnoses that tend to have poorer prognoses, such as mesothelioma and lung cancer, especially in the first 6 months after diagnosis [12, 13]. Individuals who have previously engaged in suicidal behaviour are likely to be particularly vulnerable. [Figure: Factors that may contribute to depression and anxiety among people living with and beyond cancer] The individual psychological response to a cancer diagnosis is also likely to be an important component. The experience of being diagnosed, particularly if the diagnosis has been delayed, can be a significant source of distress and can impact on illness acceptance [14]. Feelings of hopelessness, loss of control and uncertainty around survival and death can also have a detrimental impact, particularly in patients with a poor prognosis. Anxiety around a cancer diagnosis can also lead to sleep disturbance, which may increase the risk of depression [15]. The stigma surrounding both mental illness and certain types of cancer, such as lung cancer, can lead to feelings of guilt and shame, which could contribute to the onset of depression. For example, the link between smoking and lung cancer can lead to some patients blaming themselves for their illness and experiencing stigma if they have engaged in smoking [14]. A variety of factors related to the cancer and its treatment are likely to impact on the development